Peptides DB

Research-centric peptide and protocol reference hub

KPV

Research-centric overview

Share
Peptide

### KPV Summary KPV is a tripeptide composed of lysine, proline, and valine, which has garnered interest in research for its potential roles in modulating immune responses and promoting wound healing. Its implications in various therapeutic contexts, particularly in inflammatory conditions, are currently being explored.

Community effect votes, structured logs, and side-effect summaries.

Effect profile (overview)

Aggregate AI baseline blended with community voting. Hover to inspect effect strengths per category.

Effect profile (AI + community): Healing & recovery 4.0/5 · Inflammation & immune 4.0/5 · Skin & aesthetics 2.0/5Healing 4.0Muscle 0.0Metabolic 0.0Neuro 0.0Sleep 0.0Inflammation 4.0Skin 2.0

Effect scores blend an AI baseline with community votes. Open the full chart to see sliders and vote on each category.

Research log summary heatmap

Compact view of how logs describe shifts in pain, sleep, and performance (−5 to +5). Treat this as qualitative, anonymous signal only.

No community research logs yet. When structured logs are added, this panel will summarize typical shifts in pain, sleep, and performance.

Anonymous side-effect patterns

Rough heatmap of anonymous side-effect and positive-signal tags — a "most-mentioned" snapshot, not safety or efficacy advice.

No anonymous side-effect reports yet. When reports are submitted, this panel will show a simple heatmap of tags like "nausea", "flushing", "improved healing", and more.

Research footprint

Last analyzed Jun 2, 2026
9
Studies indexed
2
Human
0
Animal
9
AI analyzed
Evidence mix22% human · 0% animal · 11% cellular · 0% review
Highest phase: Preclinical onlyYears covered: 2026
Librarian pulse — latest actionsFull changelog ↓
  • Jun 1, 6:00 AMRefreshedRefreshed content for KPV
  • May 31, 6:00 AMRefreshedRefreshed content for KPV
  • May 30, 6:00 AMRefreshedRefreshed content for KPV

Research & intelligence feed

Studies, clinical trials, community discussions, and news.

Diagnostic Yield and Safety of Medical Thoracoscopic Biopsy in Undiagnosed Exudative Pleural Effusion: A Five-Year Retrospective Study From a Tertiary Care Center in South India.StudyPubMedPublished Jan 1, 2026Added Apr 16, 2026

Medical thoracoscopic biopsy has an 87.5% diagnostic yield for undiagnosed exudative pleural effusions, with a complication rate of 6.25%.

Diagnostic Yield and Safety of Medical Thoracoscopic Biopsy in Undiagnosed Exudative Pleural Effusion: A Five-Year Retrospective Study From a Tertiary Care Center in South India.StudyPubMedPublished Jan 1, 2026Added Apr 16, 2026

Medical thoracoscopic biopsy had an 87.5% diagnostic yield in patients with undiagnosed exudative pleural effusion, but the findings should be interpreted with caution due to study limitations.

Semantic Scholar search for KPVStudySemanticScholarAdded Dec 12, 2025

Not reported in abstract.

Challenges in clinical nutrition research in Latin America: A narrative review.StudyPubMedAdded Dec 12, 2025

Not reported in abstract.

Exploring the Role of Tripeptides in Wound Healing and Skin Regeneration: A Comprehensive Review.StudyPubMedAdded Dec 12, 2025

Not reported in abstract.

Host defense peptides as a new drug lead to a strategy for inflammatory bowel disease.StudyPubMedAdded Dec 12, 2025

Not reported in abstract.

External databases

Helpful external resources for additional structural, pharmacologic, and literature context. These are third-party databases; always cross-check details with primary research.

Community notes

No comments yet. Share research notes, citations, or observations below.

Comments appear immediately.

Community research logs (detail)

No community research logs yet. Use the “Contribute data” button above to share an anonymized summary of your experience.

Anonymous side-effect reporting (detail)

This section describes how anonymous side-effect reports are aggregated into the heatmap above. Reports are anonymous and unverified, and should be read alongside primary safety data.

Use the "Report side effects" button to open a focused popup form. Please keep descriptions neutral and avoid medical language; think in terms of "nausea", "flushing", "vivid dreams", etc.

Librarian Changelog

Every time the Librarian touches this peptide — discovering, refreshing, scoring, or verifying — it logs the action here.

1d agoRefreshai-researcher80%

Refreshed content for KPV

2d agoRefreshai-researcher80%

Refreshed content for KPV

3d agoRefreshai-researcher80%

Refreshed content for KPV

4d agoRefreshai-researcher80%

Refreshed content for KPV

6d agoRefreshai-researcher80%

Refreshed content for KPV

May 26Scoring70%

Scored effects for KPV

May 26Verificationai-researcher90%

Verified content for KPV: accurate

Apr 20Refreshdiscovery50%

Refreshed content for KPV

Apr 20SummarySemanticScholar0%

Auto-summarized study: "Semantic Scholar search for KPV..."

Apr 17Refreshai-researcher85%

Refreshed content for KPV

Apr 16Refreshai-researcher85%

Refreshed content for KPV

Apr 16Refreshai-researcher85%

Refreshed content for KPV